CRISPR-Cas Clinical Trial Update
Nov. 17, 2020
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Allife Medical Science and Technology
Main focus: Next generation cellular therapies
Company stage: Clinical
Diseases: Beta-thalassemia, haematological and solid tumours
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Beijing, China
Website: http://www.allifetech.com/
Allife Medical Science and Technology is a company focused on developing next generation cellular therapies for the treatment of genetic diseases and cancers. The company uses CRISPR to genetically modify its cellular products, and currently runs multiple clinical trials.
Tags
Allife Medical Science and Technology Co., Ltd
Clinical Trials
IND Enabling
Phase I
Phase II
Phase III
